Conserved influenza virus surface epitopes

Conserved surface epitopes of influenza virus proteins are highly stable antigenic regions located on the viral envelope proteins, primarily the hemagglutinin (HA) stalk, the matrix protein 2 ectodomain (M2e), and specific sites on neuraminidase (NA) (NIH, 2014; MDPI, 2020). Unlike the immunodominant globular head of HA, which undergoes rapid antigenic drift, these conserved regions remain relatively unchanged across diverse influenza A and B strains (NIH, 2014; NIH, 2019). The biological function of these targets is critical for viral fitness; for instance, the HA stalk mediates the pH-dependent membrane fusion required for viral entry, while M2e is part of an ion channel essential for viral uncoating (Frontiers, 2021; NIH, 2019). Therapeutic strategies targeting these epitopes include broadly neutralizing antibodies (bnAbs) and universal vaccine candidates designed to elicit heterosubtypic immunity (NIH, 2009; NIH, 2019). Drugs such as MEDI8852 and VIR-2482 bind to these conserved sites to neutralize the virus by blocking entry or engaging host immune effector functions like antibody-dependent cellular cytotoxicity (ADCC) (NIH, 2014; NIH, 2019).

Other names

Universal influenza vaccine targetsConserved influenza antigensBroadly reactive influenza epitopesHemagglutinin stalkHA stemMatrix protein 2 ectodomainM2eConserved neuraminidase epitopes

Neutralization of viral entry by blocking hemagglutinin-mediated membrane fusion or receptor binding, inhibition of viral release via neuraminidase targeting, and induction of Fc-mediated effector functions such as antibody-dependent cellular cytotoxicity (ADCC).